Iovance Biotherapeutics
Emily Cicalese is an IT Business Operations Analyst II at Iovance Biotherapeutics, Inc. since March 2022, bringing a robust background in quality systems and manufacturing analysis from previous roles at Adaptimmune and GSK. At Adaptimmune, Emily held the position of Senior Quality Systems Specialist and contributed as a Manufacturing Execution System Analyst and Cell Therapy Manufacturing Specialist. Before that, experience at GSK included roles as a Biopharmaceutical Manufacturing Associate I and Production Execution SME focusing on SAP M-ERP. Emily's educational background features a Bachelor of Science degree from Lehigh University, complemented by participation in the Lehigh Silicon Valley experiential entrepreneurship program and the Altitude Student Leadership Conference.
This person is not in any teams
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.